Zhang Y - Search Results

1

New-generation advanced PROTACs as potential therapeutic agents in cancer therapy.

Wang C, Zhang Y, Chen W, Wu Y, Xing D. Wang C, et al. Among authors: zhang y. Mol Cancer. 2024 May 21;23(1):110. doi: 10.1186/s12943-024-02024-9. Mol Cancer. 2024. PMID: 38773495 Free PMC article. Review.

2

A strategy for qualitative and quantitative profiling of glycyrrhiza extract and discovery of potential markers by fingerprint-activity relationship modeling.

Zhang Y, Wang C, Yang F, Sun G. Zhang Y, et al. Sci Rep. 2019 Feb 4;9(1):1309. doi: 10.1038/s41598-019-38601-y. Sci Rep. 2019. PMID: 30718789 Free PMC article.

3

Design, synthesis and evaluation of antiproliferative and antitubulin activities of 5-methyl-4-aryl-3-(4-arylpiperazine-1-carbonyl)-4H-1,2,4-triazoles.

Wang C, Li Y, Liu T, Wang Z, Zhang Y, Bao K, Wu Y, Guan Q, Zuo D, Zhang W. Wang C, et al. Among authors: zhang w, zhang y. Bioorg Chem. 2020 Nov;104:103909. doi: 10.1016/j.bioorg.2020.103909. Epub 2020 May 4. Bioorg Chem. 2020. PMID: 33142419

4

Design, synthesis and anticancer activity of 5-aryl-4-(4-arylpiperazine-1-carbonyl)-1,2,3-thiadiazoles as microtubule-destabilizing agents.

Wang C, Wang Z, Gao M, Li Y, Zhang Y, Bao K, Wu Y, Guan Q, Zuo D, Zhang W. Wang C, et al. Among authors: zhang w, zhang y. Bioorg Chem. 2021 Jan;106:104199. doi: 10.1016/j.bioorg.2020.104199. Epub 2020 Aug 26. Bioorg Chem. 2021. PMID: 33317837

5

PROTACs technology for targeting non-oncoproteins: Advances and perspectives.

Wang C, Zhang Y, Xing D, Zhang R. Wang C, et al. Among authors: zhang r, zhang y. Bioorg Chem. 2021 Sep;114:105109. doi: 10.1016/j.bioorg.2021.105109. Epub 2021 Jun 21. Bioorg Chem. 2021. PMID: 34175722 Review.

6

Developments of CRBN-based PROTACs as potential therapeutic agents.

Wang C, Zhang Y, Wu Y, Xing D. Wang C, et al. Among authors: zhang y. Eur J Med Chem. 2021 Dec 5;225:113749. doi: 10.1016/j.ejmech.2021.113749. Epub 2021 Aug 10. Eur J Med Chem. 2021. PMID: 34411892 Review.

7

Emerging Tubulin Inhibitors: A New Hope for Fungicides.

Wang C, Zhang Y, Xing D. Wang C, et al. Among authors: zhang y. J Agric Food Chem. 2021 Sep 29;69(38):11151-11153. doi: 10.1021/acs.jafc.1c04048. Epub 2021 Sep 17. J Agric Food Chem. 2021. PMID: 34533025 No abstract available.

8

VHL-based PROTACs as potential therapeutic agents: Recent progress and perspectives.

Wang C, Zhang Y, Wang J, Xing D. Wang C, et al. Among authors: zhang y. Eur J Med Chem. 2022 Jan 5;227:113906. doi: 10.1016/j.ejmech.2021.113906. Epub 2021 Oct 9. Eur J Med Chem. 2022. PMID: 34656901 Review.

9

Design, synthesis, and biological evaluation of biotinylated colchicine derivatives as potential antitumor agents.

Wang C, Zhang Y, Wang Z, Li Y, Guan Q, Xing D, Zhang W. Wang C, et al. Among authors: zhang w, zhang y. J Enzyme Inhib Med Chem. 2022 Dec;37(1):411-420. doi: 10.1080/14756366.2021.2013832. J Enzyme Inhib Med Chem. 2022. PMID: 34915785 Free PMC article.

10

UHPLC-ESI-Q-TOF-MS/MS analysis, antioxidant activity combined fingerprints for quality consistency evaluation of compound liquorice tablets.

Zhang Y, Wang C, Yang F, Yang Z, Wang F, Sun G. Zhang Y, et al. RSC Adv. 2018 Aug 3;8(49):27661-27673. doi: 10.1039/c8ra02431f. eCollection 2018 Aug 2. RSC Adv. 2018. PMID: 35542699 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262,813 results

Search Page

Filters